BIRMINGHAM, AL, ContinuumRx announces that it has closed on $7 million in new financing led by Mitsui & Co. Global Investment.
for more funding data on ContinuumRx
To export ContinuumRx funding data to PDF and Excel, click here
ContinuumRx announces that it has closed on $7 Million in new financing. The financing was led by Mitsui & Co. Global Investment, Inc.; Health Enterprise Partners, L.P. (HEP); and local investors, including Fidelis Capital Partners, Redmont Venture Partners, and Stonehenge Capital Company. The new capital is to be used for continued growth throughout the southeastern U.S.
"Securing this growth capital from quality investors is vital to our long-terms goals," said Chuck Jett, ContinuumRx's Chairman and CEO. "We signed our first joint venture agreement with the University of Tennessee Medical Center in November of 2010. Today, with our joint venture partners, we serve patients and physicians at eight major healthcare systems operating 30 hospitals and medical centers in Tennessee, Mississippi, and Alabama."
About ContinuumRx, Inc.
ContinuumRx is based in Birmingham, Alabama and develops joint ventures with market-leading health systems to seek to improve patient outcomes through better coordination in the hospital-to-home transition. Through its unique integrated model with health systems and their affiliated providers, ContinuumRx is creating a better model of care for patients with chronic and complex conditions. Its team of clinical experts and advanced fulfillment model provides hospitals with a seamless service offering that can reduce the patient's length of stay, help avoid unnecessary readmissions, and allow payors to reduce overall healthcare costs. For more information, please visit www.continuumrx.com.